Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
8/14/2024 | $5.00 | Buy | Rosenblatt | |
8/12/2024 | $3.00 → $4.75 | Hold → Buy | Canaccord Genuity | |
8/9/2024 | $25.00 | Neutral → Overweight | JP Morgan | |
8/9/2024 | Mkt Perform → Outperform | William Blair | ||
8/7/2024 | $120.00 → $144.00 | Neutral → Outperform | Exane BNP Paribas | |
8/7/2024 | $65.00 → $55.00 | Buy | TD Cowen | |
7/24/2024 | $150.00 → $140.00 | Buy | Canaccord Genuity | |
7/19/2024 | Underperform → Neutral | Macquarie |
Prepares for September 17, 2024, Evie Ring back in stock dateAnnounces brand partnership with digital creator Heidi D'AmelioFocuses on launch of EvieMED and securing B2B opportunitiesConference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif., Aug. 14, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a pioneer in health technology, reported second quarter 2024 results and provided a business update. Following the successful close of the Company's April 2024 $24.1 million private placement that included a seed investment from a tier 1 multi-billion dollar medical device
GREENWICH, Conn., Aug. 14, 2024 (GLOBE NEWSWIRE) -- QXO, Inc. (NASDAQ:QXO) today announced its second quarter results for the three and six months ended June 30, 2024. Financial Highlights for the Three Months Ended June 30, 2024, Compared with the Three Months Ended June 30, 2023: Total revenue was $14.54 million, compared with $13.26 million.Software product revenue was $3.78 million, compared with $3.30 million.Service and other revenue was $10.76 million, compared with $9.96 million.Net loss was ($591,000) or ($9.93) loss per basic and diluted share, compared with net income of $344,000 or $0.52 earnings per basic and diluted share.Adjusted EBITDA, a non-GAAP measure, was ($1.21) mil
Ondas secures initial purchase orders for Iron Drone Raider from a global defense company and a major military customerMajor military customer places additional purchase order to expand the initial Iron Drone program, as announced earlier todayAmerican Robotics secures key contract with United States Coast Guard for maritime emissions monitoring to support EPA Clean Ports initiativesIron Drone Raider is emerging as a best-in-class 'hard kill' counter drone solution addressing the urgent need for protection from hostile dronesOndas Networks' distribution partner secures initial purchase order for deployment on 900 MHZ from transit operator in SouthwestConference Call Scheduled for Today at 8:
FREMONT, Calif., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, announced today that it has started shipping its most powerful home battery to-date, the IQ® Battery 5P™, in the Netherlands. Enphase also introduced IQ® Energy Management, its new energy management software to enable support for dynamic electricity rates and the integration of third-party EV chargers and heat pumps in the Netherlands. The IQ Battery 5P enables configurations ranging from 5 to 60 kWh and offers a significantly improved experience for homeowners and installers due to mo
Accenture (NYSE:ACN) has made a strategic investment, through Accenture Ventures, in Earli Inc., a biotechnology company that developed a novel approach to early cancer detection with a synthetic targeting platform that selectively reprograms cancer cells to reveal and destroy themselves. This investment from Accenture Ventures will support expanding collaborations with global health and pharma companies that can use Earli's technology to more rapidly and accurately detect and treat cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240819448521/en/Accenture has made a strategic investment, through Accenture Ventures, in Ear
Hong Kong, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Abits Group Inc (NASDAQ:ABTS) is pleased to announce its half-year results for the period ended June 30, 2024. In a period when production is sustained throughout the six months, revenue grew to $3.67 million comprising 61.5 bitcoins, compared to the previous period when construction of the mining center in Tennessee was in progress and there was no production.. After accounting for direct costs of revenue amounting to $2.68 million, primarily electricity costs of $1.1 million and depreciation of $1.27 million, the gross profit from the mining operation was $0.75 million. The loss before tax of the group was $0.14 million after accounting
6-K - Abits Group Inc (0001864055) (Filer)
S-8 - Movano Inc. (0001734750) (Filer)
144 - Enphase Energy, Inc. (0001463101) (Subject)
Rosenblatt resumed coverage of TeraWulf with a rating of Buy and set a new price target of $5.00
Canaccord Genuity upgraded Blend Labs from Hold to Buy and set a new price target of $4.75 from $3.00 previously
JP Morgan upgraded Confluent from Neutral to Overweight and set a new price target of $25.00
SC 13D/A - TERAWULF INC. (0001083301) (Subject)
SC 13G - QXO, Inc. (0001236275) (Subject)
SC 13G - QXO, Inc. (0001236275) (Subject)
Accenture (NYSE:ACN) has made a strategic investment, through Accenture Ventures, in Earli Inc., a biotechnology company that developed a novel approach to early cancer detection with a synthetic targeting platform that selectively reprograms cancer cells to reveal and destroy themselves. This investment from Accenture Ventures will support expanding collaborations with global health and pharma companies that can use Earli's technology to more rapidly and accurately detect and treat cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240819448521/en/Accenture has made a strategic investment, through Accenture Ventures, in Ear
Accomplished Executive Brings Decades of Technology Leadership Experience Samsara Inc. ("Samsara") (NYSE:IOT), the pioneer of the Connected Operations™ Cloud, today announced the appointment of Alyssa Henry to its Board of Directors. Henry joins an accomplished group of board members including Marc Andreessen, Jonathan Chadwick, Sue Wagner, Sue Bostrom, Ann Livermore, Todd Bluedorn, and Samsara co-founders Sanjit Biswas and John Bicket. Henry brings over 25 years of leadership experience in software engineering and development, with a proven track record of driving innovation, scaling operations, and achieving significant growth in the technology sector. Henry served as Chief Executiv
Hong Kong, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Abits Group Inc., a leading global Bitcoin mining enterprise, is thrilled to announce the appointment of Christopher Silva as Vice President of HR and Business Development, effective May 1, 2024. Christopher brings over 30 years of extensive experience in human capital management, talent acquisition, and business development. Known for his innovative and results-oriented sourcing strategies, he has a proven track record in executive leadership, sales, and human resources across diverse corporate cultures, both domestically and internationally. In his new role at Abits Group Inc., Christopher will oversee HR Operations and spearhead talent acqu
4 - Confluent, Inc. (0001699838) (Issuer)
4 - Crexendo, Inc. (0001075736) (Issuer)
4 - TERAWULF INC. (0001083301) (Issuer)
4 - Blend Labs, Inc. (0001855747) (Issuer)
4 - Crexendo, Inc. (0001075736) (Issuer)
4 - Blend Labs, Inc. (0001855747) (Issuer)
International Business Machines Corporation (NYSE:IBM) shares are moving higher on Thursday after the company reported strong second quarter earnings. What To Know: IBM reported 2024 fiscal year second quarter results after the market closed on Wednesday. The company reported adjusted EPS at $2.43 beating analysts estimate of $2.19. In addition, IBM reported sales of $15.80 billion beating analyst estimates of $15.61 billion. The reported revenue represents a 2% increase from the same period last year. IBM further broke down its revenue for the second quarter. The company reported revenue from software at $6.7 billion, revenue from consulting at $5.2 billion, revenue from infrastru
Stifel analyst David Grossman maintains IBM (NYSE:IBM) with a Buy and raises the price target from $190 to $205.